VANGUARD GROUP INC - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 33 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$443,718
-6.4%
1,267,766
+0.1%
0.00%
Q3 2022$474,000
-22.2%
1,266,834
-4.6%
0.00%
Q2 2022$609,000
-8.3%
1,327,910
+0.0%
0.00%
Q1 2022$664,000
-26.1%
1,327,710
-15.8%
0.00%
Q4 2021$899,000
-40.8%
1,576,658
+6.9%
0.00%
Q3 2021$1,519,000
-14.3%
1,475,307
-0.1%
0.00%
Q2 2021$1,772,000
+7.2%
1,477,107
+16.2%
0.00%
Q1 2021$1,653,000
-55.9%
1,271,589
+24.5%
0.00%
Q4 2020$3,748,000
+81.1%
1,021,296
+5.6%
0.00%
Q3 2020$2,070,000
+16.6%
967,577
-2.5%
0.00%
Q2 2020$1,776,000
+35.5%
992,3770.0%0.00%
Q1 2020$1,311,000
-27.4%
992,3770.0%0.00%
Q4 2019$1,806,000
-37.0%
992,3770.0%0.00%
Q3 2019$2,868,000
+9.8%
992,377
+1.4%
0.00%
Q2 2019$2,613,000
+7.4%
978,606
+2.6%
0.00%
Q1 2019$2,432,000
+82.2%
953,432
+97.8%
0.00%
Q4 2018$1,335,000
-84.8%
481,904
-51.2%
0.00%
Q3 2018$8,802,000987,8600.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$206,0000.12%
Baker Brothers Advisors 4,608,786$16,914,0000.06%
Artal Group S.A. 500,000$1,835,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 90,000$331,0000.04%
Spotlight Asset Group, Inc. 21,500$79,0000.03%
DCF Advisers, LLC 18,755$69,0000.03%
683 Capital Management, LLC 88,470$325,0000.02%
Palo Alto Investors LP 77,044$283,0000.02%
Alpine Global Management, LLC 13,966$51,0000.01%
TCI Wealth Advisors, Inc. 4,000$15,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders